ReviewCurrent hypertension reports2022

The Time to Reconsider Mineralocorticoid Receptor Blocking Strategy: Arrival of Nonsteroidal Mineralocorticoid Receptor Blockers.

Yuta Tezuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.